w 7 has been researched along with Ovarian Neoplasms in 12 studies
W 7: RN given refers to parent cpd; structure; calmodulin antagonist
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Effects of N-(6-aminohexyl)-1-naphthalenesulfonamide (W-5) and N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (ftorafur, FT) and a mixture of FT and uracil (UFT) were determined in nude mice bearing human ovarian carcinoma (KF cells)." | 7.67 | Adjuvant effects of calmodulin antagonists on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (ftorafur) and a mixture of ftorafur and uracil (UFT) in nude mice bearing human ovarian carcinomas. ( Iwano, I; Kikuchi, Y; Kita, T; Kizawa, I; Kuki, E; Miyauchi, M; Oomori, K, 1989) |
| "Effects of N-(6-aminohexyl)-1-naphthalenesulfonamide (W-5) and N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (ftorafur, FT) and a mixture of FT and uracil (UFT) were determined in nude mice bearing human ovarian carcinoma (KF cells)." | 3.67 | Adjuvant effects of calmodulin antagonists on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (ftorafur) and a mixture of ftorafur and uracil (UFT) in nude mice bearing human ovarian carcinomas. ( Iwano, I; Kikuchi, Y; Kita, T; Kizawa, I; Kuki, E; Miyauchi, M; Oomori, K, 1989) |
| "The adjuvant effect of calmodulin antagonists (W-5 and W-7) to 5-fluorouracil (5-FU) was studied by using two human cultured cell lines derived from ovarian adenocarcinoma." | 3.67 | Adjuvant effects of calmodulin antagonists to 5-fluorouracil on tumor cell proliferation and the mechanisms. ( Kato, K; Kikuchi, Y; Kizawa, I; Oomori, K, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (91.67) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kikuchi, Y | 11 |
| Iwano, I | 7 |
| Kato, K | 8 |
| Hidaka, H | 1 |
| Miyauchi, M | 7 |
| Sasa, H | 1 |
| Nagata, I | 2 |
| Kuki, E | 3 |
| Oomori, K | 8 |
| Kizawa, I | 8 |
| Kita, T | 6 |
| Hirata, J | 1 |
1 review available for w 7 and Ovarian Neoplasms
| Article | Year |
|---|---|
[Pharmacology of calmodulin : calmodulin antagonist (author's transl)].
Topics: Animals; Calcium-Binding Proteins; Calmodulin; Cattle; Cricetinae; Diamines; Female; Mice; Neoplasms | 1981 |
11 other studies available for w 7 and Ovarian Neoplasms
| Article | Year |
|---|---|
Effects of calmodulin antagonists on human ovarian cancer cell proliferation in vitro.
Topics: Calmodulin; Cell Division; Cell Line; Cisplatin; Cystadenocarcinoma; Doxorubicin; Female; Humans; Ov | 1984 |
Restorative effects of calmodulin antagonists on reduced cisplatin uptake by cisplatin-resistant human ovarian cancer cells.
Topics: Biological Transport; Calmodulin; Cisplatin; Cystadenocarcinoma; Drug Resistance; Female; Humans; Ov | 1990 |
Adjuvant effects of calmodulin antagonists on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (ftorafur) and a mixture of ftorafur and uracil (UFT) in nude mice bearing human ovarian carcinomas.
Topics: Animals; Calmodulin; Carcinoma; Drug Combinations; Drug Synergism; Female; Fluorouracil; Mice; Mice, | 1989 |
[The mechanism of resistance and its circumvention of cisplatin-resistant human ovarian cancer cells].
Topics: Animals; Biological Transport; Calmodulin; Cisplatin; Drug Resistance; Female; Humans; Mice; Mice, N | 1989 |
[Effect of calmodulin antagonists (W-5 and W-7) on antitumor activity of Tegafur and UFT (Tegafur plus uracil)].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Calmodulin; Drug Synergism; Female; Mice; M | 1988 |
Enhancement of antineoplastic effects of cisplatin by a calmodulin antagonist (W-7) in nude mice bearing human ovarian carcinoma.
Topics: Animals; Cisplatin; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude | 1988 |
[Potentiation of the antitumor effect of cisplatin by calmodulin antagonists (W-7 and W-5) in nude mice bearing human ovarian carcinoma].
Topics: Animals; Calmodulin; Cisplatin; Drug Synergism; Drug Therapy, Combination; Female; Mice; Mice, Nude; | 1988 |
Establishment of a cisplatin-resistant human ovarian cancer cell line.
Topics: Calmodulin; Cell Division; Cell Line; Cisplatin; Drug Resistance; Female; Humans; Ovarian Neoplasms; | 1986 |
Enhancement of antineoplastic effects of cisplatin by calmodulin antagonists in nude mice bearing human ovarian carcinoma.
Topics: Adenocarcinoma; Animals; Calmodulin; Cisplatin; Cytotoxicity, Immunologic; Drug Administration Sched | 1987 |
Adjuvant effects of calmodulin antagonists to 5-fluorouracil on tumor cell proliferation and the mechanisms.
Topics: Adenocarcinoma; Calmodulin; Cell Division; Cell Line; Female; Fluorouracil; Humans; Ovarian Neoplasm | 1987 |
Restorative effects of defective autologous lymphocyte cytotoxicity by calmodulin antagonists.
Topics: Adenocarcinoma; Adult; Animals; Calmodulin; Cell Line; Cystadenocarcinoma; Cytotoxicity, Immunologic | 1985 |